Eagle Pharmaceut earned $2.73 per diluted share in fiscal year 2022. This represents an increase of 513.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to $0.91 per diluted share. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters Eagle Pharmaceut has filed alongside them.
FY2022 annual
EPS (Diluted)$2.73
YoY+513.6%
5Y CAGR-3.5%
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2023, ended Jun 30, 2023ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
EGRX EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Eagle Pharmaceut's diluted earnings per share in fiscal year 2022?
Eagle Pharmaceut earned $2.73 per diluted share in fiscal year 2022.
How fast is Eagle Pharmaceut's diluted earnings per share growing?
Eagle Pharmaceut (EGRX) diluted earnings per share rose by 513.6% year over year, from -$0.66 to $2.73 in fiscal year 2022.
What is Eagle Pharmaceut's diluted earnings per share over the last twelve months?
Eagle Pharmaceut (EGRX) reported $0.91 per diluted share over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
What was Eagle Pharmaceut's diluted earnings per share in the most recent quarter?
Eagle Pharmaceut (EGRX) reported $0.39 in diluted earnings per share in Q2 2023. This represents an increase of 152.7% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Eagle Pharmaceut (EGRX) reported on that line in every period on record.
